20 LATEST RESOURCES (191 INDEXED)
×
A Comparison between Amitriptyline and Riboflavin (Vitamin B2) for Being Used in Childhood Abdominal Migraine Prophylaxis (Meetings-Events) · June 2023
Abstracts
Archives of Disease in Childhood
×
Methadone Treatment for Opioid Use Disorder – Improving Access through Regulatory and Legal Change: Proceedings of a Workshop (Meetings-Events) · July 2022
Publications (Books-Reports)
National Academies Press
×
Efficacy of Memantine Compared to Sodium Valproate as Prophylactic Treatment for Migraine: A Pilot Clinical Trial (Meetings-Events) · May 2022
Abstracts
Neurology
×
Early Intervention with Midazolam Nasal Spray and Efficacy in Patients with Seizure Clusters: Post-Hoc Analysis of an Open-Label Extension Trial (Meetings-Events) · May 2022
Abstracts
Neurology
×
Patient-Reported Treatment Outcomes in the Mayo Clinic REM Sleep Behavior Disorder Registry: Efficacy of Melatonin and Clonazepam (Meetings-Events) · May 2021
Abstracts
Sleep
×
Methadone Maintenance Treatment, Sex Hormones and Low Bone Density in a Population of Injection Drug Users (Meetings-Events) · May 2021
Abstracts
Journal of the Endocrine Society
×
Glutamate and Response to Clozapine in Treatment Resistant Schizophrenia (Meetings-Events) · May 2020
Abstracts
Schizophrenia Bulletin
×
Comparison of Rehospitalization Rate in Individuals with Schizophrenia Changed from Paliperidone Palmitate to Oral Antipsychotics (Meetings-Events) · May 2020
Abstracts
Schizophrenia Bulletin
×
Clozapine Combination and Augmentation Strategies in Patients with Schizophrenia -Recommendations from an International Expert Survey among the Treatment Response and Resistance in Psychosis (TRRIP) Working Group (Meetings-Events) · May 2020
Abstracts
Schizophrenia Bulletin
×
ECT versus Sham for Clozapine Resistant Schizophrenia: A Secondary Analysis of a Pilot Study Based on PANSS-30 Factor Analytic Dimensions and the PANSS-6 (Meetings-Events) · May 2020
Abstracts
Schizophrenia Bulletin
×
Heart Rate Variability Predicts Clozapine Plasma Level in Patients with Schizophrenia in a Polypharmacy Condition (Meetings-Events) · May 2020
Abstracts
Schizophrenia Bulletin
×
Long-Term Benzodiazepine Use during Maintenance Therapy of Psychosis: Association with Symptoms, Cognition and Functionality (Meetings-Events) · May 2020
Abstracts
Schizophrenia Bulletin
×
Effect of Long-Acting Injections of Paliperidone Palmitate on Clinical and Functional Outcomes in Patients with Schizophrenia Based on Illness Duration (Meetings-Events) · May 2020
Abstracts
Schizophrenia Bulletin
×
Clozapine and Electroconvulsive Therapy Augmentation in Adolescents with Treatment-Resistant Schizophrenia (Meetings-Events) · May 2020
Abstracts
Schizophrenia Bulletin
×
Switching from Risperidone to Paliperidone Palmitate in Schizophrenia: Changes in Cognitive Function (Meetings-Events) · May 2020
Abstracts
Schizophrenia Bulletin
×
Factors Associated with Clozapine Response and Resistance in Schizophrenia (Meetings-Events) · May 2020
Abstracts
Schizophrenia Bulletin
×
A Systematic Review and Meta-Analysis of Clinical Variables Associated with Response to Clozapine in Treatment Resistant Schizophrenia (Meetings-Events) · May 2020
Abstracts
Schizophrenia Bulletin
×
Ultra-Resistant Schizophrenia Is Associated with a Delay to Initiate Clozapine and with Less Abdominal Obesity: Sex Differences in Insulinemia and Leptin Levels Are Observed between Responders and Not Responders (Meetings-Events) · May 2020
Abstracts
Schizophrenia Bulletin
×
Sex-Related Differences in Clozapine Side Effects in Patients with Treatment-Resistant Schizophrenia (Meetings-Events) · May 2020
Abstracts
Schizophrenia Bulletin